{"id":"W2793121285","doi":"10.1080/10428194.2017.1365855","title":"Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study","year":2018,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rituximab; Vincristine; Mantle cell lymphoma; Internal medicine; Bortezomib; Hazard ratio; Prednisone; CHOP; Neutropenia; Gastroenterology; Cyclophosphamide; Autologous stem-cell transplantation; Transplantation; Bendamustine; Surgery; Oncology; Lymphoma; Chemotherapy; Confidence interval; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002792651,0.0008457558,0.001347264,0.0002774563,0.0002316981,0.0008200141,0.0005150968,0.0006441541,0.0008992815],"category_scores_gemma":[0.001606487,0.0003697833,0.001714327,0.0002294804,0.0004993056,0.0004829692,0.0002988629,0.001328778,0.0001999666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006006535,"about_ca_system_score_gemma":0.0006767836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004548751,"about_ca_topic_score_gemma":0.001559523,"domain_scores_codex":[0.998926,0.0007740312,0.00005068647,0.0001037344,0.00006264677,0.00008284103],"domain_scores_gemma":[0.9988397,0.0003884847,0.0003198988,0.0001080073,0.00005283067,0.0002910996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9383959,0.005144942,0.02366303,0.0002904547,0.00247067,0.0001109408,0.00009742848,0.0006566042,0.006473551,0.00004764524,0.0006185272,0.02203038],"study_design_scores_gemma":[0.5488815,0.2988818,0.1395202,0.00007183519,0.004679816,0.000393174,0.0001143081,0.002454786,0.003163983,0.0002921395,0.001495537,0.00005095968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985315,0.0009022299,0.000064939,0.00006365982,0.00002204858,0.00009391666,0.0001066613,0.000008237851,0.000206705],"genre_scores_gemma":[0.9988508,0.0002865175,0.0001139198,0.0001345507,0.00004968953,0.00009689265,0.0003030274,0.000003444883,0.0001610716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002792651,"threshold_uncertainty_score":0.01476914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01009036101339514,"score_gpt":0.2737931567597365,"score_spread":0.2637027957463414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}